Shandong Weigao Adopts Formal Board Diversity Policy

Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has shared an announcement.

Shandong Weigao Group Medical Polymer Company Limited has formally adopted a Board Diversity Policy to guide the composition and appointment of its directors. The company underscores that a mix of skills, regional and industry experience, background, race, gender and other attributes is essential to improving overall board performance and decision-making.

Under the policy, all board appointments will continue to be made on merit, but diversity, including gender diversity, will be explicitly factored into determining the optimal board mix. This move signals an effort to align with evolving corporate governance standards and may strengthen the company’s strategic oversight and appeal to investors focused on environmental, social and governance practices.

The most recent analyst rating on (HK:1066) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.

More about Shandong Weigao Group Medical Polymer Co

Shandong Weigao Group Medical Polymer Company Limited is a PRC-incorporated joint stock company operating in the medical polymer products industry. The company focuses on manufacturing and supplying medical devices and related polymer-based products for healthcare markets, positioning itself as a quality-oriented player in China’s medical sector.

Average Trading Volume: 15,774,087

Technical Sentiment Signal: Sell

Current Market Cap: HK$20.08B

Find detailed analytics on 1066 stock on TipRanks’ Stock Analysis page.